Drug Utilization Review and Safety Related Drug Labeling Changes:Focus on HIV/AIDS Related Therapies


Date: Mar 28, 2023 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Apr 25, 2023 10:00 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacists
Physician Assistants
Physicians
Nurse Practitioners
Case Managers

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Registration Closed  

Needs Statement: : Optimal medication management of populations with HIV/AIDS requires pharmacists and other healthcare providers to understand how medication related quality measures impact community pharmacies. 
 
Statement of Goal:  To equip the practicing pharmacist with current knowledge and understanding of topics related to HIV-DUR and Safety Labeling. 

Objectives

  • Describe an optimal method to conduct a concurrent/retrospective drug utilization evaluation for antiretroviral drugs in a target patient population.
  • Identify at least one opportunity for improvement in a patient case obtained from an actual DUR program.
  • Describe recent FDA safety drug labeling changes for commonly used antiretrovirals and HIV/AIDS related drug therapies.

Speaker(s)/Author(s)

Dr. Christopher Keeys, Pharm.D.,BCPS, Pharm.D., BCPS
President, Clinical Pharmacy Associates, Inc.

Activity Number

0010-9999-23-018-L05-P
Date: 03/28/23
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
Registration Closed